9:00am - 5:00pm

Office Hours Mon. - Fri.


Call Us For Free Consultation



CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma

Estimated reading time: < 1 min



Estimated Enrollment: 336

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Participant, Care Provider, Investigator, Outcomes Assessor|Primary Purpose: Treatment

Study ID Numbers: 22864|2016-003111-35|CA290841|A21400

Study First Received: February 10, 2017

Last Updated: April 11, 2017

Estimated Primary Completion Date: June 2021

Primary Outcome Measures:

Overall survival|modified RECIST or RECIST 1.1 – progression free survival|modified RECIST or RECIST 1.1 – overall response rate|EQ-5D-5L|CTCAE V4.03|Health resource use questionnaire

Sponsors and Collaborators:

University of Southampton|University of Leicester|University of Sheffield|Queen Mary University of London|Queen’s University, Belfast|Velindre NHS Trust|Beatson West of Scotland Cancer Centre

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT03063450

Was this article helpful?
Views: 62